Respiratory Trials·org

Topic

Smoking cessation

Pharmacotherapy, e-cigarettes, and the cardiovascular safety question.

What the evidence shows

Stopping smoking is still the most effective thing in respiratory medicine. A cessation programme that succeeded in only one in five participants nonetheless reduced all-cause mortality over 14.5 years (Lung Health Study) — an effect no inhaler has approached.

E-cigarettes outperform nicotine replacement for one-year abstinence, 18.0% against 9.9%, when both are supported behaviourally (TEC). The finding usually quoted without its companion is that most successful quitters were still vaping at a year; whether that is durable harm reduction or substituted dependence, this trial cannot say.

Does stopping smoking change mortality?

Trial Year Therapy Effect Finding
Lung Health Study 2005 Smoking cessation programme A cessation programme that worked for one in five participants still reduced all-cause mortality over 14.5 years

E-cigarettes for cessation

Trial Year Therapy Effect Finding
TEC 2019 E-cigarettes E-cigarettes nearly doubled one-year quit rates compared with nicotine replacement

Key references

Guidelines, standards and reviews for this topic.

Studies not yet summarised

On the reading list for this topic and awaiting a full record. Listed here so nothing is hidden.